stocks logo

MIRA Valuation

Mira Pharmaceuticals Inc
$
1.270
+0.050(+4.100%)
  • Overview
  • Forecast
  • Valuation
  • Earnings

MIRA Relative Valuation

MIRA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MIRA is overvalued; if below, it's undervalued.

Historical Valuation

P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
18.84
P/B
Median3y
11.47
Median5y
11.47
-25.72
FCF Yield
Median3y
-24.68
Median5y
-24.68

Competitors Valuation Multiple

The average P/S ratio for MIRA's competitors is 30.24, providing a benchmark for relative valuation. Mira Pharmaceuticals Inc Corp (MIRA) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
Revenue Growth
Market Cap
stocks logo
MIRA.O
Mira Pharmaceuticals Inc
Loss
Average P/S: 30.24
20.64M
stocks logo
NAII.O
Natural Alternatives International Inc
Loss
14.44%
20.70M
stocks logo
MTEX.O
Mannatech Inc
Loss
-9.63%
18.06M
stocks logo
SNYR.O
Synergy CHC Corp
0.37
17.67M
stocks logo
IBIO.A
Ibio Inc
180.30
13.51M
stocks logo
PRPH.O
Prophase Labs Inc
0.77
-39.26%
13.31M

People Also Watch

stocks logo
AAPL
Apple Inc
199.930
USD
+2.39%
stocks logo
MSFT
Microsoft Corp
458.680
USD
+1.89%
stocks logo
META
Meta Platforms Inc
641.300
USD
+2.27%
stocks logo
NVDA
NVIDIA Corp
135.335
USD
+3.08%
stocks logo
TSLA
Tesla Inc
359.870
USD
+6.05%
stocks logo
XOM
Exxon Mobil Corp
103.410
USD
+0.37%
stocks logo
AMZN
Amazon.com Inc
206.300
USD
+2.64%
stocks logo
WMT
Walmart Inc
97.315
USD
+1.01%
stocks logo
ORCL
Oracle Corp
162.075
USD
+3.91%
stocks logo
AVGO
Broadcom Inc
235.530
USD
+2.98%

FAQ

arrow icon

Is Mira Pharmaceuticals Inc (MIRA) currently overvalued or undervalued?

Mira Pharmaceuticals Inc (MIRA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Mira Pharmaceuticals Inc (MIRA) is between to according to relative valuation methord.
arrow icon

What is Mira Pharmaceuticals Inc (MIRA) fair value?

arrow icon

How does MIRA's valuation metrics compare to the industry average?

arrow icon

What is the current P/B ratio for Mira Pharmaceuticals Inc (MIRA) as of May 27 2025?

arrow icon

What is the current FCF Yield for Mira Pharmaceuticals Inc (MIRA) as of May 27 2025?

arrow icon

What is the current Forward P/E ratio for Mira Pharmaceuticals Inc (MIRA) as of May 27 2025?

arrow icon

What is the current Forward P/S ratio for Mira Pharmaceuticals Inc (MIRA) as of May 27 2025?